je.st
news
Vivus: Qsymia Sales Dip - Is A Lower Price Needed?
2015-02-08 09:08:40| Biotech - Topix.net
Vivus investors have seen Qsymia scripts remain in a pretty tight channel for over 15 months. While the sales have remained fairly steady, the arrival of a new competitor could have shifted the market in such a way that Vivus will have little choice but to respond.
Tags: price
sales
needed
lower
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||